Addition of rIL-6 to IL-6-dependent B9 cells starved for IL-6 for 16-20 h stimulated a vigorous proliferative response. Glucocorticoids (GCs), in a concentration-dependent manner, inhibited rIL-6-stimulated proliferation of B9 cells This inhibition was specific for the GCs, evident by the capacity of the GCs, dexamethasone, prednisolone, and hydrocortisone, but not non-GC steroids, to suppress rIL-6-dependent B9 cell proliferation. Furthermore, GC inhibition of IL-6-stimulated B9 cell proliferation was receptor mediated and was abrogated by the GC receptor antagonist, RU486. In addition to their reported effects on inhibition IL-6 expression, the results presented support the notion that GCs also acted distally by suppressing signal transduction through the IL-6 receptor.
INTRODUCTION
stimulated proliferation of B9 cells. This, in addition to previous reports describing inhibitory effect of GCs on As anti-inflammatory and immunosuppressive drugs, signaling through the IL-2R (7, 15, 17) , expands our unglucocorticoids (GCs) exert their effects through several derstanding of the scope of immunosuppression medimechanisms, targeting both proximal and distal events ated by the GCs. of T-cell activation (1) . Inhibition of cytokine production is emerging as the most significant mechanism by MATERIALS AND METHODS which GCs exert their immunosuppressive effects (3, Cell Culture 23). In this regard, GCs inhibited T-cell and monocyte-
The murine IL-6-dependent hybridoma cell line B9 macrophage cytokine expression at the transcriptional (11) was generously provided by Dr. L. Aarden (Amand posttranscriptional levels (1). In addition, GCs ensterdam, Netherlands). B9 cells were cultured in DMEM hanced the expression of select (proinflammatory) cyto-(Gibco BRL, Mississauga, Canada) supplemented with 2 kine receptors on target cells by upregulating the denmM L-glutamine (Gibco BRL), penicillin-streptomycin sity, but not affinity, of receptors for their ligands (2, 16 ).
(100 IU and 100 µg/ml, respectively, Gibco BRL), 1 Furthermore, GCs inhibited cytokine-driven proliferamM sodium pyruvate (Gibco BRL), 10% FCS (Gibco tion of primary T-cell cultures (7, 20) , and cytokine-de-BRL), and 20% (v/v) overnight culture supernatants of pendent cell lines (15,17), an indication that GCs also nonstimulated human peripheral blood mononuclear act posttranscriptionally by inhibiting signaling through cells (as source of IL-6). cytokine receptors.
Here we extend earlier findings pertaining to the inReagents and Drugs hibitory effect of GCs on signal transduction through Dexamethasone (DEX), prednisolone (Pred), and hycytokine receptors. Using the proliferation of the IL-6-drocortisone (HC) were purchased from Sigma Chemidependent hybridoma cells, B9 (11) , as biological readcal Company (St. Louis, MO), and were prepared as 10 out system, and a panel of GCs, here we demonstrate mM stock solutions in 70% ethanol. Human rlL-6 was that in addition to decreasing the bioavailability of IL-6 generously provided by Dr. Steven Gillis (Immunex, Se-(5,23), GCs also acted posttranscriptionally by attenuatattle, WA). All further dilutions were made in DMEM. ing signaling through the IL-6R, exemplified by IL-6- Proliferation Assay 6-stimulated B9 proliferation. This inhibitory effect of GCs on rIL-6-driven proliferation of B9 cells was GC B9 cells were washed in PBS and cultured for 16 h specific, evidenced by the ability of the GCs DEX, Pred, in DMEM/10% FCS ("IL-6 starvation"). Starved B9
and HC and the failure of non-GCs (data not shown) to cells (10 5 cells/ml) were cultured in triplicate in 96-well inhibit B9 cell proliferation, in line with our previous flat-bottom microtiter plates (Nunc, Gibco BRL), treated findings pertaining to the selectivity of GCs in inhibiting with drugs or controls, and stimulated with rlL-6 (100 proliferation of human peripheral blood T cells (4). Fur-U/ml). Treated and stimulated B9 cells were incubated thermore, the effect of GCs was receptor mediated, evifor 68-72 h at 37°C. [ Although the target of GC action in blocking IL-6 Statistical Analysis proliferative signal was not assessed here, it is unlikely that it involved blockade of the high-affinity IL-6 recepFor proliferation assays, all determinations were done tor expression, because GCs upregulated the expression in triplicate, and the mean ± SD of individual experiof the IL-6R on human and murine cells in the face of ments was calculated. Analysis of variance (ANOVA) lost ligand (IL-6) stimulation (2,16). Binding of IL-6 to followed by Student-Newman-Keuls (SNK) tests were its high-affinity receptor induces the dimerization of the performed to assess intergroup differences. Statistical signal transducing receptor chain, gp130 (12), resulting significance was set at p < 0.05.
in the activation of JAK tyrosine kinase and rapid and RESULTS reversible phosphorylation of multiple intracellular target molecules. These include signal transducers and actiGCs Inhibit rIL-6-Stimulated B9 Cell Proliferation vators of transcription (Stat) (14, 22) , mitogen-activated The effect of the GCs DEX, Pred, and HC on IL-6-protein kinase (MAPK) (14) , calmodulin-dependent stimulated B9 cell proliferation was examined. B9 cells protein kinase (9) , and the PI3 kinase (12) . Although (10 4 cells), treated with the GCs or ethanol (vehicle connot addressed here, it is plausible that GCs may act by trol), were stimulated with rlL-6 (100 U) and cultured antagonizing the function of IL-6-stimulated tyrosinefor an additional 68-72 h. Whereas the proliferation of phosphorylated intracellular signaling molecules, includethanol-treated B9 cells was not statistically different ing Stat3 homodimer or Stat1-Stat3 heterodimer (14, 21) . from those of positive control, GCs in a concentrationThis was supported by reports describing physical assodependent manner inhibited rIL-6-stimulated B9 cell ciation of the GC receptor with Stat-5 (8,13), and other proliferation (Fig. 1) . DEX was the most potent of the signal transduction modalities (6,10), in altering tranthree GCs tested, as assessed by comparing EC 50 values scriptional activation. (concentration yielding 50% suppression).
Results demonstrated that GCs affect IL-6 expression Specificity of GC Effect on B9 Cell Proliferation at two stages. As shown earlier (5, 23) , GCs acted proximally by decreasing the availability of IL-6 through supThe specificity of GCs in inhibiting rIL-6-driven B9 pression of IL-6 mRNA expression (5, 23) . As shown cell proliferation was assessed by treating B9 cells treated here, GCs acted more distally by attenuating the IL-6 with GCs (DEX) and stimulated with rIL-6 with the GC effect on target cells. This, in addition to their reported receptor antagonist, RU486. Although RU486 treatment effects on suppression of IL-2 synthesis (3), and action resulted in a slight decline in rIL-6-stimulated B9 cell (15,17), underscores the complexity and uniqueness of proliferation (statistically not significant) (Fig. 2) , addiimmunosuppressive effects of GCs among current imtion of RU486 to GCs-treated and rIL-6-stimulated B9 munosuppressants, and provides for a rational framecells resulted in abrogation of GC effects and hence reswork for their use in managing heightened ongoing imtoration of the proliferative response to control values mune responses, in particular those associated with (Fig. 2) . This demonstrated that GC inhibition of B9 cell acute allograft rejection episodes (18,19). Further studproliferation was a receptor-mediated process.
ies are required to elucidate the target of GC action in DISCUSSION inhibiting signaling through the IL-6 receptor. While GCs were previously shown to block signal 
17), this is the first demonstration that GCs inhibited

